Evidence map›Paper›PMID 34689167›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2022

Sensitive period-regulating genetic pathways and exposure to adversity shape risk for depression.

Yiwen Zhu, Min-Jung Wang, Katherine M Crawford, Juan Carlos Ramírez-Tapia, Alexandre A Lussier, Kathryn A Davis, Christiaan de Leeuw, Anne E Takesian, Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium, Takao K Hensch and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Epigenetic regulation of brain development, plasticity, and response to early-life stress.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Yiwen ZhuCenter for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA. yiwenzhu@mail.harvard.edu.
Min-Jung WangCenter for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
Katherine M CrawfordCenter for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
Juan Carlos Ramírez-TapiaCenter for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0002-0962-5555
Alexandre A LussierCenter for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0002-1179-0621
Kathryn A DavisCenter for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
Christiaan de LeeuwCenter for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, Department of Complex Trait Genetics, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0003-1076-9828
Anne E TakesianEaton-Peabody Laboratories, Massachusetts Eye & Ear and Department of Otorhinolaryngology and Head/Neck Surgery, Harvard Medical School, Boston, MA, USA.
Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium
Takao K HenschCenter for Brain Science, Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-0748-8152
Jordan W SmollerCenter for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0002-0381-6334
Erin C DunnCenter for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA. edunn2@mgh.harvard.edu.ORCID http://orcid.org/0000-0003-1413-3229
Harvard University · USMassachusetts General Hospital · USBroad Institute · USAmsterdam Neuroscience · NLBoston University · USMassachusetts Eye and Ear Infirmary · US

Funding

Genetic Analysis and Manipulation Core (GAEC)P50HD105351 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI SCOTT Loren POMEROY, MUSTAFA SAHIN · 2021 to 2026
$9.4M
Childhood adversity, DNA methylation, and risk for depression: A longitudinal study of sensitive periods in developmentR01MH113930 · NIMH · PURDUE UNIVERSITY · PI Erin Cathleen Dunn · 2017 to 2026
$6.6M
Research and Mentoring on Integrating Psychiatric Genetics and NeuroscienceK24MH094614 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI SMOLLER, JORDAN W · 2012 to 2016
$925k
Genes, early adversity, and sensitive periods in social-emotional developmentK01MH102403 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI DUNN, ERIN CATHLEEN · 2014 to 2017
$710k
Medical Research Council G9815508Medical Research Council MC_PC_15018Medical Research Council MC_PC_19009NICHD NIH HHS P50 HD105351NIMH NIH HHS K01 MH102403NIMH NIH HHS K24 MH094614NIMH NIH HHS R01 MH113930Wellcome Trust 217065/Z/19/Z
6 · The paper itself

Abstract

Animal and human studies have documented the existence of developmental windows (or sensitive periods) when experience can have lasting effects on brain structure or function, behavior, and disease. Although sensitive periods for depression likely arise through a complex interplay of genes and experience, this possibility has not yet been explored in humans. We examined the effect of genetic pathways regulating sensitive periods, alone and in interaction with common childhood adversities, on depression risk. Guided by a translational approach, we: (1) performed association analyses of three gene sets (60 genes) shown in animal studies to regulate sensitive periods using summary data from a genome-wide association study of depression (n = 807,553); (2) evaluated the developmental expression patterns of these genes using data from BrainSpan (n = 31), a transcriptional atlas of postmortem brain samples; and (3) tested gene-by-development interplay (dGxE) by analyzing the combined effect of common variants in sensitive period genes and time-varying exposure to two types of childhood adversity within a population-based birth cohort (n = 6254). The gene set regulating sensitive period opening associated with increased depression risk. Notably, 6 of the 15 genes in this set showed developmentally regulated gene-level expression. We also identified a statistical interaction between caregiver physical or emotional abuse during ages 1-5 years and genetic risk for depression conferred by the opening genes. Genes involved in regulating sensitive periods are differentially expressed across the life course and may be implicated in depression vulnerability. Our findings about gene-by-development interplay motivate further research in large, more diverse samples to further unravel the complexity of depression etiology through a sensitive period lens.

Indexed as

DepressionGenome-Wide Association StudyBrainChild, PreschoolHumansInfantLife Change EventsRisk Factors

Identifiers

PMID34689167
PMCPMC8674315
OpenAlexW3161296378

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.